Eligibility, Compliance and Persistence of Sequential Therapy with Aromatase Inhibitors following 2–3 Years of Tamoxifen in Endocrine Adjuvant Breast Cancer Therapy

By  

Oncology, Vol. 81, Iss. 3-4, 2011-10 ,pp. : 151-157

Karger

Access to resources Recommend Favorite

Defining the role of aromatase inhibitors in the adjuvant endocrine treatment of early breast cancer

By Buzdar Aman   Chlebowski Rowan   Cuzick Jack   Duffy Sean   Forbes John   Jonat Walter   Ravdin Peter    

Current Medical Research and Opinion, Vol. 22, Iss. 8, 2006-08 ,pp. : 1575-1585

Informa Healthcare

Access to resources Recommend Favorite

The Emerging Role of Aromatase Inhibitors in the Adjuvant Management of Breast Cancer

By  

Reviews on Recent Clinical Trials, Vol. 1, Iss. 3, 2006-09 ,pp. : 237-249

Bentham Science Publishers

Access to resources Recommend Favorite

Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early stage breast cancer

By Ligibel Jennifer A   Winer Eric P  

Women's Health, Vol. 2, Iss. 1, 2006-01 ,pp. : 89-97

Future Medicine

Access to resources Recommend Favorite

Sequential Treatment with Exemestane and Non-Steroidal Aromatase Inhibitors in Advanced Breast Cancer

By  

Oncology, Vol. 69, Iss. 6, 2006-02 ,pp. : 471-477

Karger

Access to resources Recommend Favorite